Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE Trial
Ariane van der Straten(University of California, San Francisco), Felix Mhlanga, Francis Martinson, Gonasagrie Nair, Zakir Gaffoor(South African Medical Research Council), Nitesha Jeenarain, Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Elizabeth Montgomery(RTI International), Samantha Siva, Krishnaveni Reddy(Perinatal HIV Research Unit), Bonus Makanani(University of Malawi), Kubashni Woeber(South African Medical Research Council), Jared M. Baeten(University of Washington), Thesla Palanee‐Phillips(University of the Witwatersrand), Petina Musara(South African Medical Research Council), Vaneshree Govender(South African Medical Research Council), Katie Schwartz(University of Wyoming), Juliane Etima(MUJHU Research Collaboration), Helen Cheng(RTI International), Arendevi Pather, Elizabeth R. Brown(Fred Hutch Cancer Center), Logashvari Naidoo(South African Medical Research Council), Mary Kate Shapley‐Quinn(Women’s Health Care), Lydia Soto‐Torres(National Institutes of Health), Nyaradzo Mgodi(University of Zimbabwe)
Cited by 46
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|623
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557